Skip to main content

AusPAR Comirnaty Original/Omicron BA.4-5 COVID-19 Vaccine

Australian Public Assessment Report
Device/Product Name
Comirnaty Original/Omicron BA.4-5 COVID-19 Vaccine
Active ingredients
tozinameran/famtozinameran
AusPAR Date
Published
Submission Number
PM-2023-03314-1-2
Submission Type
Extension of indications/New strength
Decision
Approved

Help us improve the Therapeutic Goods Administration site